ASSESSMENT OF DRY BODY-WEIGHT IN HEMODIALYSIS-PATIENTS BY THE BIOCHEMICAL MARKER CGMP

被引:37
作者
LAUSTER, F [1 ]
GERZER, R [1 ]
WEIL, J [1 ]
FULLE, HJ [1 ]
SCHIFFL, H [1 ]
机构
[1] UNIV MUNICH,KINDERKLIN,W-8000 MUNICH 2,GERMANY
关键词
ANP; cGMP; Dry body-weight; Haemodialysis;
D O I
10.1093/ndt/5.5.356
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
We investigated whether cGMP might be a suitable marker of ideal weight in chronic haemodialysis patients. In 20 patients on chronic haemodialysis (10 males, 10 females, mean age 55.5±7.4 years; mean interdialytic weight gain 2.4±1.1 kg) we determined plasma ANP and cGMP values before and after several haemodialysis treatments. ANP and cGMP before haemodialysis were markedly elevated (ANP 255 + 190 pg/ml; cGMP 28.6 + 16.2 pmol/ml). A significant decrease was found after haemodialysis (ANP 169±88 pg/ml; cGMP 13.5 + 7.4 pmol/ml). These values were still well above normal. There was a significant positive correlation between excessive body-weight ΔP (difference between actual weight and estimated ideal weight), indicating fluid overload and ANP before (r = 0.57; P<0.001) and after haemodialysis (r = 0.47; P<0.001) as well as cGMP before (r = 0.42; P<0.01) and after haemodialysis (r = 0.85; P< 0.0001). With cGMP and ΔP after haemodialysis, the correlation appeared to be close enough for clinical application. All patients with a cGMP value of 18 pmol/ml or more after haemodialysis had an excessive body-weight of at least 0.5 kg. We conclude from these data that the plasma cGMP value determined immediately after haemodialysis is a sensitive marker for hyperhydration in patients with end-stage renal disease. © 1990 European Dialysis and Transplant Association-European Renal Association.
引用
收藏
页码:356 / 361
页数:6
相关论文
共 19 条
[1]   EFFECT OF HEMODIALYSIS ON PLASMA-CONCENTRATIONS OF ATRIAL-NATRIURETIC-PEPTIDE IN ADULT PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
ANDERSON, JV ;
RAINE, AEG ;
PROUDLER, A ;
BLOOM, SR .
JOURNAL OF ENDOCRINOLOGY, 1986, 110 (02) :193-196
[2]   THE RELATIONSHIP BETWEEN PLASMA-LEVELS OF IMMUNOREACTIVE ATRIAL NATRIURETIC HORMONE AND HEMODYNAMIC FUNCTION IN MAN [J].
BATES, ER ;
SHENKER, Y ;
GREKIN, RJ .
CIRCULATION, 1986, 73 (06) :1155-1161
[3]   PLASMA CLEARANCE RATES AND RENAL CLEARANCE OF H-3-LABELED CYCLIC-AMP AND H-3-LABELED CYCLIC GMP IN DOG [J].
BLONDE, L ;
WEHMANN, RE ;
STEINER, AL .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (01) :163-172
[4]  
Cannella G, 1987, Nephrol Dial Transplant, V2, P158
[5]  
DERAY G, 1988, KIDNEY INT, V34, pS86
[6]   PLASMA-VOLUME CHANGES INDUCED BY SEQUENTIAL ULTRAFILTRATION-HEMODIALYSIS AND SEQUENTIAL HEMODIALYSIS-ULTRAFILTRATION [J].
DIMAGGIO, A ;
BASILE, C ;
SCATIZZI, A .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1987, 10 (05) :291-294
[7]  
EISENHAUER T, 1986, KLIN WOCHENSCHR, V64, P68
[8]   PLASMA-LEVELS OF ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
HASEGAWA, K ;
MATSUSHITA, Y ;
INOUE, T ;
MORII, H ;
ISHIBASHI, M ;
YAMAJI, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) :819-822
[9]  
HAUN G, 1965, MED KLIN, V48, P2
[10]  
HEIM JM, 1988, Z KARDIOL, V77, P41